Health 2025: AI Revolutionizes Biotech Breakthroughs

The year 2025 has seen significant advancements in health and biotechnology, with various breakthroughs and developments that have shaped the industry. According to a report by the team at MIT Technology Review, artificial intelligence has been increasingly incorporated into more aspects of life, including healthcare. Weight-loss drugs have expanded in scope, and there have been notable advancements in gene therapy, IVF, neurotech, and other areas. MIT Technology Review's colleague Antonio Regalado has compiled a list of the year's worst technologies, highlighting the importance of evaluating the impact of emerging technologies on society. In an effort to test readers' knowledge of the year's developments, the publication invites readers to take a quiz on the year in health and biotechnology. The quiz aims to assess how closely individuals have been paying attention to the Checkup emails that have been landing in their inboxes throughout the year. According to Jessica Hamzelou, a writer for The Checkup, the sunshine vitamin, vitamin D, has been found to have a significant impact on the immune system and heart health. Research has shown that vitamin D plays a crucial role in regulating the immune system and may have a protective effect on the heart. This finding has significant implications for public health, particularly in regions with limited access to sunlight. The team at MIT Technology Review has been working on their 2026 list of breakthrough technologies, which will be published in the new year. The list is expected to feature the most significant advancements in health and biotechnology, providing readers with a comprehensive overview of the industry's progress. In an interview, Antonio Regalado noted that the year 2025 has seen a significant increase in the development of gene therapies, with several companies making breakthroughs in this area. Regalado stated, "Gene therapies have the potential to revolutionize the treatment of genetic diseases, and we've seen significant progress in this area over the past year." The industry's focus on gene therapies and other emerging technologies has led to increased investment in research and development. According to industry analysts, the global gene therapy market is expected to reach $25 billion by 2028, driven by the growing demand for effective treatments for genetic diseases. As the year comes to a close, the biotechnology industry is looking forward to the next developments in health and biotechnology. The publication of the 2026 list of breakthrough technologies is expected to provide readers with a comprehensive overview of the industry's progress and highlight the most significant advancements in the field.